Related Experiment Video
Updated: May 7, 2026

07:14
Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Leiomyosarcoma leptomeningeal brain metastases
1McGill University Health Centre; Montreal, Canada - sagi.kaduri@mail.mcgill.ca.
The Neuroradiology Journal
|September 14, 2013
Summary
Brain metastases from soft tissue sarcomas (STS) are rare and typically occur late. Advanced MRI techniques are crucial for detecting small, challenging intracranial leptomeningeal and perivascular space lesions.
Area of Science:
- Neurology
- Oncology
- Radiology
Background:
- Brain metastases from soft tissue sarcomas (STS) are uncommon, usually appearing late in disease progression, often after lung metastases.
- Intracranial STS metastases are predominantly intraparenchymal.
- Leptomeningeal and perivascular space involvement can be subtle and difficult to detect.
Purpose of the Study:
- To describe two cases of intracranial metastatic soft tissue leiomyosarcomas.
- To highlight the diagnostic challenges of small leptomeningeal and perivascular metastases.
- To recommend optimal MRI techniques for detecting these lesions.
Main Methods:
- Case report of two patients with histologically confirmed intracranial metastatic soft tissue leiomyosarcomas.
- Detailed analysis of MRI findings, focusing on lesion detection and characterization.
- Evaluation of MRI parameters, including slice thickness and contrast enhancement.
Main Results:
- Nodular metastases ≤10 mm in the leptomeningeal spaces were detectable by MRI.
- Larger lesions became difficult to distinguish from intra-axial masses.
- Small lesions in leptomeningeal and perivascular spaces posed detection challenges.
Conclusions:
- Global gadolinium-enhanced MRI with contiguous 1 mm slice thickness is recommended for detecting small intracranial STS metastases.
- Accurate detection of lesion multiplicity and location is vital for patient management.
- Advanced MRI protocols improve the identification of rare, challenging brain metastases.

